RankingsPricing
  1. JP-listed companies
  2. Human Metabolome Technologies, Inc.
  3. Financials
  4. Cash and cash equivalents

Human Metabolome Technologies, Inc.JP:6090

Market cap
¥3.9B
P/E ratio
14.4x
SummaryFinancialsHistoryOwnershipWorkforce
Period EndCash and cash equivalents (Million JPY)YoY (%)
Jun 30, 20251,562-12.64%
Jun 30, 20241,789+7.95%
Jun 30, 20231,657+10.10%
Jun 30, 20221,505+20.86%
Jun 30, 20211,245+11.26%
Jun 30, 20201,119+17.99%
Jun 30, 2019948-5.56%
Mar 31, 20191,004-20.39%
Mar 31, 20181,261-17.03%
Mar 31, 20171,520+59.68%
Mar 31, 2016952-1.12%
Mar 31, 2015963

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)